Animal Welfare

A tranquiliser shortage is holding back rescue and rehabilitation of rhinos in India

The lack of Etorphine is already holding up translocation plans in several protected areas, and preventing veterinarians from caring for injured animals.

“Watching a rhino get tranquilised is indeed an experience to cherish. It is hard to imagine that such a powerful animal can become so vulnerable too,” said Dharanidhar Boro, an officer on special duty at Manas National park, who has been working with greater one-horned rhinos in India’s Assam state since 1987.

He describes the frenzy as more than 30 trained elephants circle a grazing rhino to try and contain it and an official with a dart gun, riding atop one of the pachyderms, shoots a drug-laden syringe at the rhino’s rump or neck.

It takes eight to 10 minutes after the needle pierces the rhino’s thick skin for the animal to go completely under; it takes off running at first, then staggers, before finally collapsing onto its chest or side. While the experience is no fun for the animal, tranquilisation makes it possible to give rhinos veterinary care, affix radio collars to track them, or safely transfer them into crates for relocation.

The most important element of the tranquilising cocktail that allows conservationists to safely knock out a 2,000-plus-kilogram (4,400-pound) rhino is a semi-synthetic opioid known as Etorphine HCl.

“Etorphine HCl is by far the best available choice for rhino immobilisation today,” said Amit Sharma, coordinator of rhino conservation at WWF-India. “Other large herbivores, [such] as elephants can still be tranquilised safely with other options, but nothing better works for rhinos.”

India’s stock of the drug, however, is alarmingly low. The states of Assam, West Bengal and Uttar Pradesh, home to the country’s rhino population, have almost run out of it. Since chemical immobilisation plays a crucial role in the monitoring and conservation of the species, this shortage is already having an impact on rhino management plans, Sharma said.

Greater one-horned rhinos running in Kaziranga National Park. Photo credit: Murali K via Flickr [Licensed under CC BY 2.0]
Greater one-horned rhinos running in Kaziranga National Park. Photo credit: Murali K via Flickr [Licensed under CC BY 2.0]

Supply-chain problems

Home to more than 2,900 greater one-horned rhinos (Rhinoceros unicornis), India does not manufacture this critical narcotic derivative and needs to import it. South Africa, where the tranquiliser is manufactured, recently banned the export of compounded drugs – including the only commercially available Etorphine HCl compound – raising questions about how India will be able to secure it in the future.

“We are in trouble regarding the procurement of the drug,” said Kushal Konwar Sarma, professor of surgery and radiology at the College of Veterinary Science in Assam. “With so many rhinos in hand and with no drug to restrain them, what will we do but to be just spectators?”

The drug was once manufactured and sold under the trade name M99 in the United States, but is no longer commercially available, Sarma said. M99 was followed by a compound drug known as Immobilon, manufactured in the United Kingdom and which, according to Sarma, was a superior medication since it contained components that helped manage stress and prevent rhinos from overheating while being revived. Immobilon, too, is now off the market.

The Etorphine currently being manufactured is registered under the trade name Captivon and available in South Africa. However, a regulation that came into force in South Africa this September says that “no medicine may be compounded by a pharmacist or licensed person... for the purpose of export” – a rule that has, for now, put Captivon out of the reach of Indian conservationists.

Sarma said he hopes it may somehow be possible to at least procure Etorphine in its simple form, even if the compounded drug isn’t available. “The picture is however not clear as yet,” he said.

Even if veterinary facilities manage to find a supplier, they could still run into roadblocks within India. As a Schedule-1 narcotic derivative, Etorphine is a highly regulated drug, making its import a long, drawn-out process.

“In India too, getting [an] import license for the drug is not easy,” said Subrata Pal Chowdhury, technical assistant in the West Bengal Wildlife Wing of the Forest Department. Even before applying to India’s Narcotics Control Bureau, which ultimately approves the import application, conservation groups and government agencies have to spend from six months to a year obtaining a range of other permits and certifications from government departments, says Chowdhury, an expert on the immobilisation and transport of wild animals.

If the NCB approves a requisition request, it then passes it on to the International Narcotics Control Board in Vienna, which clears the drug company to make the delivery. However, even before South Africa banned Captivon exports, the Indian government had gone years without passing along requisition requests, Chowdhury said. The last time Odisha State’s Nandankanan Zoo, the officially designated import licensee and the facility responsible for distributing the drug to other institutions, received a shipment was in the 2009-2010 fiscal period.

According to Nandankanan Director Sisir Kumar Acharya, requisition orders from states including Uttar Pradesh, Assam, West Bengal, Bihar and Chhattisgarh are still pending, due to the absence of supply from manufacturers. The Assam state government procured it via alternative channels in 2014-2015, but has not managed to renew stocks since.

A greater one-horned rhino in Assam State’s Pobitora National Park. Photo credit: Travelling Slacker via Flickr [Licensed under CC BY 2.0]s
A greater one-horned rhino in Assam State’s Pobitora National Park. Photo credit: Travelling Slacker via Flickr [Licensed under CC BY 2.0]s

Effects on the ground

In the meantime, both critical rescue work and ambitious relocation plans have stalled.

“Our second phase of rhino reintroduction program in Dudhwa National Park is held up in absence of this drug,” said Sunil Choudhary, Dudhwa’s field director.

From seven rhinos brought to the park in 1984, Dudhwa now hosts 34 at its Sonaripur Range. While the success story is encouraging, park officials are wary of the possibility of inbreeding, which can lower the immunity of the existing population. Consequently, Choudhary said, officials plan to move two or three female rhinos and bring in a new male, in hopes of establishing a second breeding population in another part of the park.

There’s just one problem: “In January 2017, when we checked our drug stock, we found they had already expired. They have a short shelf life between 12 months [and] 18 months,” Choudhary said. The state is currently attempting to obtain its own import license for the rhino tranquiliser.

Assam is also keeping its fingers crossed for the availability of the drug. “Winter is the best time for rhino relocation, as the administering anesthesia releases heat from the animal’s body, and accordingly we had plans to do so in Manas and Laokhowa from Pobitora and Kaziranga respectively, by February 2018,” said Assam Veterinary College’s Sarma. “But if we can’t procure the drug our program will fail.”

Assam State’s Manas Park, for example, urgently needs the drug, both to allow translocation and for veterinary care. The park has about 10 females and 15 males, which is leading to fighting among the males, said special duty officer Boro. One rhino has already sustained a leg injury, likely due to such sparring. Without Etorphine, the caretakers are helpless. “Proper treatment would have helped the animal to recover faster, but we had no choice but to simply monitor it from a distance and leave the rest to nature,” Boro said.

West Bengal, another rhino range state, still has a small stock of Etorphine left for emergency use. However, the drug has already passed its official expiration date, says Pradeep Vyas, recently retired as the state’s chief wildlife warden. The drug is known to retain its efficacy for at least a few years, he said, but officials there are working to acquire more stock.

With more rhinos straying from their habitats as carrying capacities are exceeded, West Bengal has plans to relocate at least 50 rhinos to new habitats within the state. Underscoring the urgency of the relocations, the body of a juvenile male rhino was found on Nov. 7 in the Dhupjhora area of Gorumara National Park. The animal, aged three or four years old, likely died from fighting, according to divisional forest officer Nisha Goswami.

A greater one-horned rhino in Kaziranga National Park. Photo credit: Murali K via Flickr [Liccensed under CC BY 2.0]
A greater one-horned rhino in Kaziranga National Park. Photo credit: Murali K via Flickr [Liccensed under CC BY 2.0]

Bibhab Talukdar, chair of the IUCN SSC Asian Rhino Specialist Group, emphasised the necessity of putting in place a regular mechanism for procuring Etorphine. “The Environment Ministry should assess its annual requirements and take it up with [the] Home Ministry that governs the Narcotic Control Bureau,” he said. He added that India needs around 50 vials of the drug per year for rhino management.

Accordingly, he said, India should place its requisition before the International Narcotics Control Board on time, so that the stock doesn’t run out and rhino management is not affected. Talukdar also called on the government to earmark an annual budget for Etorphine and entrust agencies such as the Central Zoo Authority and the Wildlife Institute of India with its procurement.

South Africa must also be made aware of the gravity of the situation in fellow rhino range countries, so that it revokes the export ban in the interest of global rhino conservation, he said.

This article first appeared on Mongabay.

We welcome your comments at
Sponsored Content BY 

The ordeal of choosing the right data pack for your connectivity needs

"Your data has been activated." <10 seconds later> "You have crossed your data limit."

The internet is an amazing space where you can watch a donkey playing football while simultaneously looking up whether the mole on your elbow is a symptom of a terminal diseases. It’s as busy as it’s big with at least 2.96 billion pages in the indexed web and over 40,000 Google search queries processed every second. If you have access to this vast expanse of information through your mobile, then you’re probably on something known as a data plan.

However, data plans or data packs are a lot like prescription pills. You need to go through a barrage of perplexing words to understand what they really do. Not to mention the call from the telecom company rattling on at 400 words per minute about a life-changing data pack which is as undecipherable as reading a doctor’s handwriting on the prescription. On top of it all, most data packs expect you to solve complex algorithms on permutations to figure out which one is the right one.


Even the most sophisticated and evolved beings of the digital era would agree that choosing a data pack is a lot like getting stuck on a seesaw, struggling to find the right balance between getting the most out of your data and not paying for more than you need. Running out of data is frustrating, but losing the data that you paid for but couldn’t use during a busy month is outright infuriating. Shouldn’t your unused data be rolled over to the next month?

You peruse the advice available online on how to go about choosing the right data pack, most of which talks about understanding your own data usage. Armed with wisdom, you escape to your mind palace, Sherlock style, and review your access to Wifi zones, the size of the websites you regularly visit, the number of emails you send and receive, even the number of cat videos you watch. You somehow manage to figure out your daily usage which you multiply by 30 and there it is. All you need to do now is find the appropriate data pack.

Promptly ignoring the above calculations, you fall for unlimited data plans with an “all you can eat” buffet style data offering. You immediately text a code to the telecom company to activate this portal to unlimited video calls, selfies, instastories, snapchats – sky is the limit. You tell all your friends and colleagues about the genius new plan you have and how you’ve been watching funny sloth videos on YouTube all day, well, because you CAN!


Alas, after a day of reign, you realise that your phone has run out of data. Anyone who has suffered the terms and conditions of unlimited data packs knows the importance of reading the fine print before committing yourself to one. Some plans place limits on video quality to 480p on mobile phones, some limit the speed after reaching a mark mentioned in the fine print. Is it too much to ask for a plan that lets us binge on our favourite shows on Amazon Prime, unconditionally?

You find yourself stuck in an endless loop of estimating your data usage, figuring out how you crossed your data limit and arguing with customer care about your sky-high phone bill. Exasperated, you somehow muster up the strength to do it all over again and decide to browse for more data packs. Regrettably, the website wont load on your mobile because of expired data.


Getting the right data plan shouldn’t be this complicated a decision. Instead of getting confused by the numerous offers, focus on your usage and guide yourself out of the maze by having a clear idea of what you want. And if all you want is to enjoy unlimited calls with friends and uninterrupted Snapchat, then you know exactly what to look for in a plan.


The Airtel Postpaid at Rs. 499 comes closest to a plan that is up front with its offerings, making it easy to choose exactly what you need. One of the best-selling Airtel Postpaid plans, the Rs. 499 pack offers 40 GB 3G/4G data that you can carry forward to the next bill cycle if unused. The pack also offers a one year subscription to Amazon Prime on the Airtel TV app.

So, next time, don’t let your frustration get the better of you. Click here to find a plan that’s right for you.


This article was produced by the Scroll marketing team on behalf of Airtel and not by the Scroll editorial team.